The current P/E ratio for Hologic stock as of Nov 5, 2025 is 30.55. This is calculated based on the TTM EPS of $2.43 and the stock price of $74.23 per share. The PE ratio has increased by 23% from its last 4 quarters average of 24.8.
The average historical PE ratio of Hologic for the last ten years is 28.28. The current price-to-earnings ratio of 30.55 is 8% more than the historical average. Analyzing the last ten years, HOLX's PE ratio reached its highest point in the Dec 2019 quarter at 163.63, when the price was $52.36 and the EPS was $0.32. The lowest point was recorded in the Jun 2021 quarter, when it reached 8.37 with a price of $65.89 and an EPS of $7.87.
Maximum annual increase: 208.47% in 2023
Maximum annual decrease: -79.04% in 2015
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 24.13 | -35.67% | $80.82 | $3.35 |
| 2023 | 37.51 | 208.47% | $69.4 | $1.85 |
| 2022 | 12.16 | 15.7% | $62.98 | $5.18 |
| 2021 | 10.51 | -30.76% | $76.48 | $7.28 |
| 2020 | 15.18 | N/A | $64.35 | $4.24 |
| 2019 | N/A | N/A | $49.61 | -$0.76 |
| 2018 | N/A | N/A | $40.98 | -$0.4 |
| 2017 | 13.59 | -58.29% | $36.69 | $2.7 |
| 2016 | 32.58 | -61.72% | $38.45 | $1.18 |
| 2015 | 85.11 | -79.04% | $40 | $0.47 |
| 2014 | 406 | N/A | $24.36 | $0.06 |
| 2013 | N/A | N/A | $20.91 | -$4.36 |
| 2012 | N/A | N/A | $20.22 | -$0.28 |
| 2011 | 26 | N/A | $15.6 | $0.6 |
| 2010 | N/A | N/A | $16.66 | -$0.24 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 26.75 | 4.25% | $65.01 | $2.43 |
| Mar 2025 | 25.66 | 12.74% | $61.32 | $2.39 |
| Dec 2024 | 22.76 | -5.68% | $72.6 | $3.19 |
| Sep 2024 | 24.13 | -4.13% | $80.82 | $3.35 |
| Jun 2024 | 25.17 | -36.73% | $74.25 | $2.95 |
| Mar 2024 | 39.78 | 18.04% | $77.96 | $1.96 |
| Dec 2023 | 33.7 | -10.16% | $71.45 | $2.12 |
| Sep 2023 | 37.51 | -9.2% | $69.4 | $1.85 |
| Jul 2023 | 41.31 | 55.13% | $80.97 | $1.96 |
| Apr 2023 | 26.63 | 40.97% | $80.7 | $3.03 |
| Dec 2022 | 18.89 | 55.35% | $74.81 | $3.96 |
| Sep 2022 | 12.16 | 2.7% | $62.98 | $5.18 |
| Jun 2022 | 11.84 | -4.59% | $70.93 | $5.99 |
| Mar 2022 | 12.41 | 9.53% | $76.05 | $6.13 |
| Dec 2021 | 11.33 | 7.8% | $76.12 | $6.72 |
The current PE ratio of HOLX is above its 3, 5 and 10-year averages.
Hologic's price to earnings (P/E) of 30.55 is higher than the Healthcare sector and its peers average but lower than the industry average. Looking at the Healthcare sector average of 25.01, Hologic's price to earnings (P/E) is 22% higher.
When compared to its peers GE and TMO, HOLX's PE ratio is lower, but it is higher than JNJ's and ABT's. Hologic's current PE ratio of 30.55 is in line with the average of its peers, which is 30.22.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ABT Abbott Laboratories | 15.56 | $216.4B |
| JNJ Johnson & Johnson | 17.89 | $449.57B |
| DGX Quest Diagnostics Inc | 20.63 | $19.83B |
| HOLX Hologic Inc | 30.48 | $16.47B |
| BDX Becton Dickinson & Co | 32.07 | $50.56B |
| TMO Thermo Fisher Scientific Inc | 32.67 | $212.83B |
| GE General Electric Co | 40.4 | $322.14B |
| BSX Boston Scientific Corp | 52.33 | $146.61B |
HOLX's price to earnings ratio is 30.55 as of Nov 5, 2025.
Over the last 3 years, the average PE ratio for HOLX stock is 29.3.
Over the last 5 years, the average PE ratio for HOLX stock is 21.73.
Over the last ten years, the Dec 2019 quarter recorded the highest quarterly PE ratio at 163.63.
The current PE ratio of HOLX is 8% higher than the 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Nov 5, 2025), Hologic's share price is $74.23. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $2.43. Therefore, Hologic's price to earnings ratio for today is 30.55. PE RATIO(30.55) = STOCK PRICE($74.23) / TTM EPS($2.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.